FIELD: medicine. SUBSTANCE: method involves applying non-penetrating deep sclerectomy. Pharmaceutical composition is additionally administered under superficial sclera flap and on the sclera surface in the antiglaucoma operation zone. The composition has cytostatic agents in the amount of 0.001-2.5 mas. %; and viscoelastic filler, the balance. EFFECT: prevented intraocular fluid hyperfiltration; prolonged operation result. 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SURGICAL METHOD FOR TREATING THE CASES OF OPEN ANGLE GLAUCOMA | 2001 |
|
RU2203638C1 |
| SURGICAL METHOD FOR TREATING GLAUCOMA | 2000 |
|
RU2196554C2 |
| SURGICAL METHOD FOR TREATING PATIENTS FOR GLAUCOMA | 2000 |
|
RU2195903C2 |
| SURGICAL METHOD FOR TREATING THE CASES OF OPEN ANGLE GLAUCOMA | 1999 |
|
RU2177288C2 |
| METHOD FOR TREATING GLAUCOMA | 2000 |
|
RU2192217C2 |
| METHOD FOR TREATING GLAUCOMA | 2001 |
|
RU2192230C1 |
| METHOD FOR TREATING ANTIGLAUCOMATOUS OPERATION COMPLICATIONS RELATED TO INTRAOCULAR FLUID HYPERFILTRATION | 2000 |
|
RU2206301C2 |
| SURGICAL METHOD FOR TREATING THE CASES OF GLAUCOMA | 2000 |
|
RU2201731C2 |
| METHOD FOR STABILIZING INTRAOCULAR PRESSURE IN POSTOPERATIVE PERIOD OF ANTIGLAUCOMATOUS OPERATIONS OF FILTRATING TYPE | 2002 |
|
RU2215504C1 |
| METHOD FOR COMBINED OPERATION AT CATARACT AND GLAUCOMA | 2000 |
|
RU2193378C2 |
